Approval · Notice of Compliance 29026 · 2022
OCALIVA: Notice of Compliance 29026
Issued September 16, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 29026
- Date
- September 16, 2022
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the Product Monograph with new safety information in pediatric patients.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| OCALIVA | Not yet assigned | — |
Medicinal ingredients
- OBETICHOLIC ACID 5 MG per TAB
- OBETICHOLIC ACID 10 MG per TAB